Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram
- PMID: 35918562
- DOI: 10.1007/s10067-022-06314-9
Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram
Abstract
Objectives: The aim of this study was to develop and assess a risk nomogram of bacterial infection in patients with ANCA-associated vasculitis (AAV) in southwest China.
Method: We established a prediction model based on a training dataset of 249 AAV patients. The least absolute shrinkage and selection operator (Lasso) was used to screen feature variables. Multivariate logistic regression analysis was used to build a prediction model for feature variables. Nomogram was used to predict the risk of bacterial infection in AAV patients. Receiver operating characteristic (ROC) curve was used to evaluate and verify the prediction accuracy of the model. Calibration and clinical useful range was assessed using calibration curve and decision curve analysis, respectively.
Results: Bactericidal permeability enhancement protein of ANCAs (BPI-ANCAs), procalcitonin (PCT), and white blood cell (WBC) were the characteristic variables in this study. Nomogram showed that positive BPI-ANCAs and PCT had higher positive predictive value for bacterial infection in AAV patients. The area under curve (AUC) of the model was 0.703 (95% confidence interval: 0.640-0.766). In the validation model, the AUC was 0.745 (95% confidence interval: 0.617-0.872). Decision curve analysis showed that the nonadherence nomogram was clinically useful within the threshold probability range of 0.31-0.85.
Conclusions: Nomogram combined with BPI-ANCAs and PCT has the guiding significance for predicting bacterial infection risk in AAV. As an ANCA-specific autoantibody, BPI-ANCAs is helpful for clinicians to understand the role of specific autoantibodies in the pathogenesis of AAV. Key Points • BPI-ANCAs, PCT, and WBC could predict bacterial infection in AAV patients. • Nomogram showed that positive BPI-ANCAs had a high positive predictive value for bacterial infection in AAV patients.
Keywords: ANCA-associated vasculitis; Bacterial infection; Laboratory data; Nomogram; Predictors.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Similar articles
-
Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study.Front Immunol. 2023 Jul 12;14:1084299. doi: 10.3389/fimmu.2023.1084299. eCollection 2023. Front Immunol. 2023. PMID: 37503353 Free PMC article.
-
Analysis of risk factors associated with diffuse alveolar haemorrhage in patients with ANCA-associated vasculitis and construction of a risk prediction model using line graph.Clin Exp Rheumatol. 2024 Apr;42(4):864-871. doi: 10.55563/clinexprheumatol/7m21vr. Epub 2024 Apr 16. Clin Exp Rheumatol. 2024. PMID: 38634373
-
The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis.Front Immunol. 2019 Jun 12;10:1334. doi: 10.3389/fimmu.2019.01334. eCollection 2019. Front Immunol. 2019. PMID: 31249574 Free PMC article.
-
Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.Curr Opin Rheumatol. 2010 Jan;22(1):43-8. doi: 10.1097/BOR.0b013e3283323538. Curr Opin Rheumatol. 2010. PMID: 19770659 Review.
-
Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.Am J Pathol. 2009 Nov;175(5):1790-8. doi: 10.2353/ajpath.2009.090533. Epub 2009 Oct 8. Am J Pathol. 2009. PMID: 19815703 Free PMC article. Review.
Cited by
-
Development and application of a risk nomogram for the prediction of risk of carbapenem-resistant Acinetobacter baumannii infections in neuro-intensive care unit: a mixed method study.Antimicrob Resist Infect Control. 2024 Jun 13;13(1):62. doi: 10.1186/s13756-024-01420-6. Antimicrob Resist Infect Control. 2024. PMID: 38867312 Free PMC article.
-
The impact on the scientific community of the 2018 addendum to the CHCC.Front Med (Lausanne). 2022 Dec 1;9:1081063. doi: 10.3389/fmed.2022.1081063. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530898 Free PMC article. No abstract available.
References
-
- Deng X, Gao J, Zhao F (2022) Identification of differentially expressed genes and pathways in kidney of ANCA-associated vasculitis by integrated bioinformatics analysis. Ren Fail 44(1):204–216. https://doi.org/10.1080/0886022X.2022.2030755 - DOI - PubMed - PMC
-
- Thery-Casari C, Euvrard R, Mainbourg S, Durupt S, Reynaud Q, Durieu I, Belot A, Lobbes H, Cabrera N, Lega JC (2020) Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides receiving rituximab: a meta-analysis. Autoimmun Rev 19(5):102505. https://doi.org/10.1016/j.autrev.2020.102505 - DOI - PubMed
-
- Hirano K, Tokui T, Inagaki M, Fujii T, Maze Y, Toyoshima H (2017) Aggregatibacter aphrophilus infective endocarditis confirmed by broad-range PCR diagnosis: a case report. Int J Surg Case Rep 31:150–153. https://doi.org/10.1016/j.ijscr.2017.01.041 - DOI - PubMed - PMC
-
- Garcia-Vives E, Segarra-Medrano A, Martinez-Valle F, Agraz I, Solans-Laque R (2020) Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome. J Rheumatol 47(3):407–414. https://doi.org/10.3899/jrheum.190065 - DOI - PubMed
-
- Mosakowska M, Kania DB, Szamotulska K, Rymarz A, Niemczyk S (2021) Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies. BMC Nephrol 22(1):290. https://doi.org/10.1186/s12882-021-02495-8 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials